28/09/2006 - With the first clinical trial of its cell culture-based seasonal influenza vaccine commencing in the US, Sanofi Pasteur has demonstrated the production scale potential of a cell line in a successful bioreactor run of 20,000L.
link to full article
Friday, September 29, 2006
Sanofi breaks ground in cell culture-based vaccine production
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment